Selected research
Industry Research
Atrial Appendage Occluder Industry Research Report 2026
Market perspective
The global Atrial Appendage Occluder market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Atrial Appendage Occluder is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Atrial Appendage Occluder is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Atrial Appendage Occluder is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Atrial Appendage Occluder include Appriva Medical Inc., AtriCure, Cardia, Inc., Coherex Medical, Occlutech, PFM Medical Ag., SentreHEART Inc., W. L. Gore & Associates and Boston Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Atrial Appendage Occluder market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Atrial Appendage Occluder Market by Company
Appriva Medical Inc.
AtriCure
Cardia, Inc.
Coherex Medical
Occlutech
PFM Medical Ag.
SentreHEART Inc.
W. L. Gore & Associates
Boston Scientific
Abbott
Atrial Appendage Occluder Segment by Type
Valvular Atrial Fibrillation
Non-valvular Atrial Fibrillation
Atrial Appendage Occluder Segment by Application
Clinics
Hospitals
Atrial Appendage Occluder Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atrial Appendage Occluder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Atrial Appendage Occluder and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atrial Appendage Occluder.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Atrial Appendage Occluder manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Atrial Appendage Occluder by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Atrial Appendage Occluder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Valvular Atrial Fibrillation
- Non-valvular Atrial Fibrillation
Applications
- Clinics
- Hospitals
Companies covered
- Appriva Medical Inc.
- AtriCure
- Cardia, Inc.
- Coherex Medical
- Occlutech
- PFM Medical Ag.
- SentreHEART Inc.
- W. L. Gore & Associates
- Boston Scientific
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Atrial Appendage Occluder Market Size (2021-2032)
- 2.2.2 Global Atrial Appendage Occluder Sales (2021-2032)
- 2.2.3 Global Atrial Appendage Occluder Market Average Price (2021-2032)
- 2.3 Atrial Appendage Occluder by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Valvular Atrial Fibrillation
- 2.3.3 Non-valvular Atrial Fibrillation
- 2.4 Atrial Appendage Occluder by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinics
- 2.4.3 Hospitals
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Atrial Appendage Occluder Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Atrial Appendage Occluder Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Atrial Appendage Occluder Revenue of Manufacturers (2021-2026)
- 3.4 Global Atrial Appendage Occluder Average Price by Manufacturers (2021-2026)
- 3.5 Global Atrial Appendage Occluder Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Atrial Appendage Occluder, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Atrial Appendage Occluder, Product Type & Application
- 3.8 Global Manufacturers of Atrial Appendage Occluder, Established Date
- 3.9 Global Atrial Appendage Occluder Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Appriva Medical Inc.
- 4.1.1 Appriva Medical Inc. Company Information
- 4.1.2 Appriva Medical Inc. Business Overview
- 4.1.3 Appriva Medical Inc. Atrial Appendage Occluder Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Appriva Medical Inc. Atrial Appendage Occluder Product Portfolio
- 4.1.5 Appriva Medical Inc. Recent Developments
- 4.2 AtriCure
- 4.2.1 AtriCure Company Information
- 4.2.2 AtriCure Business Overview
- 4.2.3 AtriCure Atrial Appendage Occluder Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AtriCure Atrial Appendage Occluder Product Portfolio
- 4.2.5 AtriCure Recent Developments
- 4.3 Cardia, Inc.
- 4.3.1 Cardia, Inc. Company Information
- 4.3.2 Cardia, Inc. Business Overview
- 4.3.3 Cardia, Inc. Atrial Appendage Occluder Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cardia, Inc. Atrial Appendage Occluder Product Portfolio
- 4.3.5 Cardia, Inc. Recent Developments
- 4.4 Coherex Medical
- 4.4.1 Coherex Medical Company Information
- 4.4.2 Coherex Medical Business Overview
- 4.4.3 Coherex Medical Atrial Appendage Occluder Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Coherex Medical Atrial Appendage Occluder Product Portfolio
- 4.4.5 Coherex Medical Recent Developments
- 4.5 Occlutech
- 4.5.1 Occlutech Company Information
- 4.5.2 Occlutech Business Overview
- 4.5.3 Occlutech Atrial Appendage Occluder Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Occlutech Atrial Appendage Occluder Product Portfolio
- 4.5.5 Occlutech Recent Developments
- 4.6 PFM Medical Ag.
- 4.6.1 PFM Medical Ag. Company Information
- 4.6.2 PFM Medical Ag. Business Overview
- 4.6.3 PFM Medical Ag. Atrial Appendage Occluder Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 PFM Medical Ag. Atrial Appendage Occluder Product Portfolio
- 4.6.5 PFM Medical Ag. Recent Developments
- 4.7 SentreHEART Inc.
- 4.7.1 SentreHEART Inc. Company Information
- 4.7.2 SentreHEART Inc. Business Overview
- 4.7.3 SentreHEART Inc. Atrial Appendage Occluder Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 SentreHEART Inc. Atrial Appendage Occluder Product Portfolio
- 4.7.5 SentreHEART Inc. Recent Developments
- 4.8 W. L. Gore & Associates
- 4.8.1 W. L. Gore & Associates Company Information
- 4.8.2 W. L. Gore & Associates Business Overview
- 4.8.3 W. L. Gore & Associates Atrial Appendage Occluder Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 W. L. Gore & Associates Atrial Appendage Occluder Product Portfolio
- 4.8.5 W. L. Gore & Associates Recent Developments
- 4.9 Boston Scientific
- 4.9.1 Boston Scientific Company Information
- 4.9.2 Boston Scientific Business Overview
- 4.9.3 Boston Scientific Atrial Appendage Occluder Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Boston Scientific Atrial Appendage Occluder Product Portfolio
- 4.9.5 Boston Scientific Recent Developments
- 4.10 Abbott
- 4.10.1 Abbott Company Information
- 4.10.2 Abbott Business Overview
- 4.10.3 Abbott Atrial Appendage Occluder Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Abbott Atrial Appendage Occluder Product Portfolio
- 4.10.5 Abbott Recent Developments
5 Global Atrial Appendage Occluder Market Scenario by Region
- 5.1 Global Atrial Appendage Occluder Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Atrial Appendage Occluder Sales by Region: 2021-2032
- 5.2.1 Global Atrial Appendage Occluder Sales by Region: 2021-2026
- 5.2.2 Global Atrial Appendage Occluder Sales by Region: 2027-2032
- 5.3 Global Atrial Appendage Occluder Revenue by Region: 2021-2032
- 5.3.1 Global Atrial Appendage Occluder Revenue by Region: 2021-2026
- 5.3.2 Global Atrial Appendage Occluder Revenue by Region: 2027-2032
- 5.4 North America Atrial Appendage Occluder Market Facts & Figures by Country
- 5.4.1 North America Atrial Appendage Occluder Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Atrial Appendage Occluder Sales by Country (2021-2032)
- 5.4.3 North America Atrial Appendage Occluder Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Atrial Appendage Occluder Market Facts & Figures by Country
- 5.5.1 Europe Atrial Appendage Occluder Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Atrial Appendage Occluder Sales by Country (2021-2032)
- 5.5.3 Europe Atrial Appendage Occluder Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Atrial Appendage Occluder Market Facts & Figures by Country
- 5.6.1 Asia Pacific Atrial Appendage Occluder Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Atrial Appendage Occluder Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Atrial Appendage Occluder Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Atrial Appendage Occluder Market Facts & Figures by Country
- 5.7.1 South America Atrial Appendage Occluder Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Atrial Appendage Occluder Sales by Country (2021-2032)
- 5.7.3 South America Atrial Appendage Occluder Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Atrial Appendage Occluder Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Atrial Appendage Occluder Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Atrial Appendage Occluder Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Atrial Appendage Occluder Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Atrial Appendage Occluder Sales by Type (2021-2032)
- 6.1.1 Global Atrial Appendage Occluder Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Atrial Appendage Occluder Sales Market Share by Type (2021-2032)
- 6.2 Global Atrial Appendage Occluder Revenue by Type (2021-2032)
- 6.2.1 Global Atrial Appendage Occluder Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Atrial Appendage Occluder Revenue Market Share by Type (2021-2032)
- 6.3 Global Atrial Appendage Occluder Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Atrial Appendage Occluder Sales by Application (2021-2032)
- 7.1.1 Global Atrial Appendage Occluder Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Atrial Appendage Occluder Sales Market Share by Application (2021-2032)
- 7.2 Global Atrial Appendage Occluder Revenue by Application (2021-2032)
- 7.2.1 Global Atrial Appendage Occluder Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Atrial Appendage Occluder Revenue Market Share by Application (2021-2032)
- 7.3 Global Atrial Appendage Occluder Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Atrial Appendage Occluder Value Chain Analysis
- 8.1.1 Atrial Appendage Occluder Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Atrial Appendage Occluder Production Mode & Process
- 8.2 Atrial Appendage Occluder Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Atrial Appendage Occluder Distributors
- 8.2.3 Atrial Appendage Occluder Customers
9 Global Atrial Appendage Occluder Analyzing Market Dynamics
- 9.1 Atrial Appendage Occluder Industry Trends
- 9.2 Atrial Appendage Occluder Industry Drivers
- 9.3 Atrial Appendage Occluder Industry Opportunities and Challenges
- 9.4 Atrial Appendage Occluder Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst